Skin Vaccination Summit 2013

4-6 September, Bell Harbor Conference Centre, Seattle, Washington, USA

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 4th September

08.00 onwards
Registration

Welcome & Opening Remarks including:

09.15-09.20
‘Welcome to Seattle’
Darin Zehrung (PATH, Seattle, Washington, USA)

Opening Remarks:

09.20-09.35
‘Overview on cutaneous vaccination’
Bruce G. Weniger (Chiang Mai University, Chiang Mai, Thailand)

SESSION 1:
PROSPECTS AND PROMISE FOR CUTANEOUS VACCINATION

Moderator: Darin Zehrung (PATH, Seattle, Washington, USA)

09.35-10.05
‘Working to Achieve the Millennium Development Goals: The role of innovation in global public health’
Anurag Mairal (PATH, Seattle, Washington, USA)

10.05-10.35
‘The potential of skin delivery technologies’
Derek O’Hagan (Novartis Vaccines & Diagnostics, Cambridge, Massachusetts, USA)

10.35-11.05
‘Design, engineering and formulation of microneedle patches for skin vaccination’
Mark Prausnitz (Georgia Institute of Technology, Atlanta, Georgia, USA)

11.05-11.25
Coffee Break & Poster Set-Up

SESSION 2:
THE CASE FOR CUTANEOUS

Moderator: Derek O’Hagan (Novartis Vaccines & Diagnostics, Cambridge, Massachusetts, USA)

11.25-11.55
‘Opportunities and challenges in achieving desirable product attributes for global public health’
Darin Zehrung (PATH, Seattle, Washington, USA)

11.55-12.15
‘Economic analysis predicts increased vaccination rates and reduced vaccination cost enabled by self-vaccination’
James J. Norman, Jaya M. Arya, Paula M. Frew and Mark R. Prausnitz (Georgia Institute of Technology, Atlanta, Georgia, USA)

12.15-12.35
‘Intradermal delivery of your vaccine, with a needle free delivery system’
Richard R. Stout and Dan Williamson (Bioject Inc., Tigard, Oregon, USA)

12.35-14.00
Lunch Break & Posters

SESSION 3:
IMMUNOLOGY AND ANATOMY FOR VACCINATING INTO SKIN

Moderator: Mark Prausnitz (Georgia Institute of Technology, Atlanta, Georgia, USA)

14.00-14.30
‘Mechanisms of epidermal and dermal immunization’
Behazine Combadiere (INSERM, Paris, France)

14.30-14.50
‘Effect of aging on influenza skin vaccination’
Dimitrios G. Koutsonanos, Stein E. Esser, Joanna A. Pulit-Penaloza, Elena E. Vassilieva, Misha T. Taherbhai, Lee Jenong-Woo, Mark R. Prausnitz, Ioanna Skountzou and Richard W. Compans (Emory University, Atlanta, Georgia, USA)

14.50-15.10
‘The role of polymorphonuclear neutrophils in innate and adaptive responses to nanopatch delivery of split virion influenza vaccine to skin’
Frances E. Pearson, Oscar L. Haigh, Alexandra Depelsenaire, Marion E.G. Brunck and Mark A.F. Kendall (University of Queensland, Brisbane, Queensland, Australia)

15.10-15.30
‘Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live recombinant virus microneedle array’
Linda S. Klavinskis, V. Bachy, C. Hervouet, P.D. Becker, L. Chorro, L.M. Carlin, S. Herath, S.-J. Ho, S.-Y. Kwon and F. Geissmann (Kings College School of Medicine, University of London, London, UK)

15.30-15.50
‘Depletion of langerin+ cells ablates adaptive immune responses to influenza vaccine delivered transdermally’
Joanna A. Pulit-Penaloza, Stein E. Esser, Lee Jeong-Woo, Elena E. Vassilieva, Misha T. Taherbhai, Dimitrios G. Koutsonanos, Mark R. Prausnitz, Richard W. Compans and Ioanna Skountzou (Emory University, Atlanta, Georgia, USA)

15.50-16.10
Tea Break & Posters

SESSION 4:
REINVENTING THE WHEAL – CLASSICAL INTRADERMAL DELIVERY

Moderator: Richard R. Stout (Bioject Inc., Tigard, Oregon, USA)

16.10-16.30
‘MicronJet600®: A novel microneedle device for ID delivery of vaccines – Clinical experience in flu, the elderly, and beyond’
Yotam Levin and Efrat Kochba (NanoPass Technologies, Rehovot, Israel)

16.30-16.50
‘Tropis – development and clinical use update’
Michael Royals (Pharmajet Inc., Golden, Colorado, USA)

16.50-17.10
‘Improved intradermal injection by Auto-Disable (AD) intradermal (ID) adapter’
Izzy Tsals (SID Technologies, Newtown, Pennsylvania, USA)

17.10-17.30
‘A novel, cost-effective and simple device for improving the administration of intradermal vaccines’
Zach Marks (West Pharmacetical Services, Lionville, Pennsylvania, USA)

17.30-17.50
‘New intradermal delivery device’
Paul Mallins (Star Syringe Ltd, Uckfield, East Sussex, UK)

18.00-19.00
SVS 2013 Posters Session

 

SVS 2013 Delegates

Login details will be supplied after you have registered for the event.


SVS 2013 Sponsors

  • PharmaJet
  • Sanaria
  • Aldevron
  • Bioject
  • Drug Delivery Letters
  • Corium
  • DNA Vaccine
  • Univac
  • West
  • Star Syringe
  • Current Drug Delivery
  • Inovio Pharmaceuticals
  • NanoPass
  • Novartis Vaccines
  • Path
  • Nature Gene Therapy
  • ONdrugDELIVERY
  • Infectious Disease Research Institute
  • Zoetis
  • Debiotech
  • Sanofi Pasteur
  • 3M
  • Becton Dickinson

SVS 2013 Downloads

SVS 2013 Leaflet

SVS 2013 Mailing List

Name
E-mail Address
What is 1+4-2?